Description Overview BPC-157 + TB-500 is a combination of two synthetic peptides widely studied in preclinical research: BPC-157 (Body Protection Compound-157) and TB-500 (Thymosin Beta-4 fragment)
Amble Health Announces the Amble Cares Program - Expanding Access to Weight Loss Program Treatments for Low-Income Americans Amble Health Announces the Amble Cares Program - Expanding Access to Weight Loss Program Treatments for Low-Income Americans PR Newswire CORTLAND, Ohio, May 6, 2026 Leveling the Starting Line: The First Telehealth Platform Bringing Affordable Access to Weight Loss Treatments to America's Disenfranchised Populations CORTLAND, Ohio, May 6, 2026 /PRNewswire/ -- Amble Health, a healthcare platform built to close the wealth gap in metabolic care, today announced the launch of the Amble Cares Program
CLINUVELs lead therapy, SCENESSE (afamelanotide 16mg), is approved for commercial distribution in Europe, the USA, Israel and Australia as the worlds first systemic photoprotective drug for the prevention of phototoxicity (anaphylactoid reactions and burns) in adult patients with erythropoietic protoporphyria (EPP)
GLP-1 analogs have been shown to help diabetes patients lose weight by inducing satiety and reducing caloric intake
10.1111/acer.14568 22
Patriarca, S., Furfaro, A
